BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27666479)

  • 1. Trifluoperazine blocks the human cardiac sodium channel, Na
    Kim DH; Lee SJ; Hahn SJ; Choi JS
    Biochem Biophys Res Commun; 2016 Oct; 479(3):584-589. PubMed ID: 27666479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inhibition by chlorpromazine of the human pain threshold sodium channel, Na
    Lee SJ; Kim DH; Hahn SJ; Waxman SG; Choi JS
    Neurosci Lett; 2017 Feb; 639():1-7. PubMed ID: 28017662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norquetiapine blocks the human cardiac sodium channel Na
    Kim DH; Park KS; Park SH; Hahn SJ; Choi JS
    Eur J Pharmacol; 2020 Oct; 885():173532. PubMed ID: 32882214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II.
    Huang Y; Zhou X; Tang C; Zhang Y; Tao H; Chen P; Liu Z
    Peptides; 2015 Jun; 68():175-82. PubMed ID: 25817910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
    Chae YJ; Choi BH; Choi JS; Hahn SJ
    Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Nav1.7 and Nav1.4 sodium channels by trifluoperazine involves the local anesthetic receptor.
    Sheets PL; Gerner P; Wang CF; Wang SY; Wang GK; Cummins TR
    J Neurophysiol; 2006 Oct; 96(4):1848-59. PubMed ID: 16807347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
    Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of A-803467 on cardiac Nav1.5 channels.
    Han Z; Jiang Y; Xiao F; Cao K; Wang DW
    Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
    Wang Y; Mi J; Lu K; Lu Y; Wang K
    PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
    Wang GK; Wang SY
    Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin.
    Zhao F; Li X; Jin L; Zhang F; Inoue M; Yu B; Cao Z
    Mar Drugs; 2016 Feb; 14(2):. PubMed ID: 26891306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin.
    Young KA; Caldwell JH
    J Physiol; 2005 Jun; 565(Pt 2):349-70. PubMed ID: 15746172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tarantula toxin jingzhaotoxin-XI (κ-theraphotoxin-Cj1a) regulates the activation and inactivation of the voltage-gated sodium channel Nav1.5.
    Tang C; Zhou X; Huang Y; Zhang Y; Hu Z; Wang M; Chen P; Liu Z; Liang S
    Toxicon; 2014 Dec; 92():6-13. PubMed ID: 25240294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
    Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
    Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
    Elajnaf T; Baptista-Hon DT; Hales TG
    Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of a human skeletal myotonia produced by mutation in the C-terminus of NaV1.4: is Ca2+ regulation defective?
    Biswas S; DiSilvestre DA; Dong P; Tomaselli GF
    PLoS One; 2013; 8(12):e81063. PubMed ID: 24324661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. μ-conotoxin TsIIIA, a peptide inhibitor of human voltage-gated sodium channel hNa
    Yang M; Zhou M
    Toxicon; 2020 Oct; 186():29-34. PubMed ID: 32758497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
    Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calmodulin inhibitor and antipsychotic drug trifluoperazine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
    Hong DH; Son YK; Li H; Jung ID; Park YM; Jung WK; Kim HS; Choi IW; Park WS
    Biochem Biophys Res Commun; 2014 Jan; 443(1):321-5. PubMed ID: 24316213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.
    Stoetzer C; Reuter S; Doll T; Foadi N; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):315-25. PubMed ID: 26667357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.